Company intelligence / Profile preview

Novarex

Cheongju, Chungbuk, South Korea

Ownership: Private
Development stage: Other

Overview

Novarex, originally founded as Rexgene Biotech in 1995, is South Korea's leading OEM/ODM health supplement manufacturer, supplying established global supplement brands. Their focus is on developing and manufacturing health supplements with ingredients that have undergone clinical trials and regulatory recognition. While R&D is emphasized for novel supplement ingredients, there is no evidence of small molecule drug or biopharmaceutical pipeline targeting classical disease indications.

Modalities: Health supplementNutraceuticalFunctional food
Industry: Food & Nutrition

Partnerships

GNC (USA)Blackmores (Australia)NOW (USA)TCI (Taiwan)

Beyond the preview

Go deeper on Novarex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novarex.

Explore the full profile